2 promoters of Laurus Labs sell 70 lakh equity shares

Published On 2021-03-05 09:23 GMT   |   Update On 2021-03-05 10:20 GMT
Advertisement

Hyderabad: Laurus Labs Ltd. has recently announced that Dr.Satyanarayana Chava, Founder Promoter, CEO & ED, sold 52 lakh equity shares of the Company in the stock market at an average price of INR.368.59, per share, aggregating to INR 191.67 Crores and Mrs. Nagarani Chava, one of the promoters of the company sold 18 Lakh equity shares of the Company at an average price of 366.91 per share at an aggregate value of INR 66.04 Crores, together 1.3% of the paid up capital of the Company.

Advertisement

Significant part of the above amount shall be utilized to release the pledge on their equity shares of the Company.

It may be recalled that the above promoters have purchased around 3% of the then paid up capital of the Company in the year 2018.

Read also: Laurus Labs bags Golden Peacock Award for Excellence in Corporate Governance 2020

Laurus Labs is an Indian pharmaceutical company headquartered in Hyderabad.

The Company's major focus areas include anti-retroviral, Hepatitis C and Oncology drugs.

Most of the Laurus Labs manufacturing facilities are approved by major regulatory authorities USFDA, WHO-Geneva, UK-MHRA, etc.



Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News